InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: McMagyar post# 350055

Tuesday, 02/08/2022 4:23:00 PM

Tuesday, February 08, 2022 4:23:00 PM

Post# of 462627
The only things that count....

Met all phase 3 and 2 endpoints


Yes, this is what actually happened in the non-pediatric Rett clinical trial, for which the results were recently revealed.

All were statistically significant, and targeted endpoints were reached. Everything else is murky message board chatter, none of which will or need be considered by the FDA when they make their blarcamesine approval decision.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News